HER2-positive, Newly Diagnosed, Primary Breast Cancer, Neoadjuvant Therapy, Trastuzumab Clinical Trial Using BKM120, Trastuzumab, Paclitaxel and Placebo

- The folks at Novartis are studying the effects of BKM120; Trastuzumab; Paclitaxel; Placebo on HER2-positive, Newly Diagnosed, Primary Breast Cancer, Neoadjuvant Therapy, Trastuzumab in females ages 18 years and older. This clinical trial is slated to start September 2013 and is expected to end circa February 2016.

+41613241111
Overall Study Contact Info
StatusName Contact Phone
RecruitingNovartis Pharmaceuticals+41613241111

This study is officially titled, "NeoPHOEBE: Pi3k Inhibition in Her2 OverExpressing Breast cancEr: A Phase II, Randomized, Parallel Cohort, Two Stage, Double-blind, Placebo-controlled Study of Neoadjuvant Trastuzumab Versus Trastuzumab + BKM120 in Combination With Weekly Paclitaxel in HER2-positive, PIK3CA Wild-type and PIK3CA Mutant Primary Breast Cancer."

Locations

Novartis Investigative Site

Porto Alegre, RS - Not yet recruiting

Novartis Investigative Site

Rio de Janiero, RJ - Not yet recruiting

Novartis Investigative Site

Fortaleza, CE - Not yet recruiting

Novartis Investigative Site

Bruxelles, Belgium - Recruiting

Novartis Investigative Site

Liege, Belgium - Not yet recruiting

Novartis Investigative Site

Concord NSW, New South Wales - Not yet recruiting

Novartis Investigative Site

Hobart, Tasmania - Not yet recruiting

Novartis Investigative Site

Geelong, Victoria - Not yet recruiting

Novartis Investigative Site

Melbourne, Victoria - Not yet recruiting

Novartis Investigative Site

Parkville, Victoria - Not yet recruiting

Novartis Investigative Site

Linz, Upper Austria - Not yet recruiting

Novartis Investigative Site

Salzburg, Austria - Not yet recruiting

Novartis Investigative Site

Vienna, Austria - Not yet recruiting

Novartis Investigative Site

Porto Alegre, RS - Not yet recruiting

Novartis Investigative Site

Florianopolis, SC - Not yet recruiting

Novartis Investigative Site

Lille Cedex, France - Not yet recruiting

Novartis Investigative Site

Nice Cedex 2, France - Not yet recruiting

Novartis Investigative Site

Paris, France - Not yet recruiting

Novartis Investigative Site

Reims, France - Not yet recruiting

Novartis Investigative Site

Toulouse, France - Not yet recruiting

Novartis Investigative Site

Villejuif Cedex, France - Not yet recruiting

Novartis Investigative Site

Tbingen, Baden-Wuertemberg - Not yet recruiting

Novartis Investigative Site

Dsseldorf, Nordrhein Westfalen - Not yet recruiting

Novartis Investigative Site

Berlin, Germany - Not yet recruiting

Novartis Investigative Site

Dortmund, Germany - Recruiting

Novartis Investigative Site

Erlangen, Germany - Not yet recruiting

Novartis Investigative Site

Essen, Germany - Recruiting

Novartis Investigative Site

Essen, Germany - Not yet recruiting

Novartis Investigative Site

Frankfurt, Germany - Not yet recruiting

Novartis Investigative Site

Gera, Germany - Not yet recruiting

Novartis Investigative Site

Halle/S., Germany - Not yet recruiting

Novartis Investigative Site

Kiel, Germany - Not yet recruiting

Novartis Investigative Site

Lbeck, Germany - Recruiting

Novartis Investigative Site

Muenchen, Germany - Not yet recruiting

Novartis Investigative Site

Muenchen, Germany - Not yet recruiting

Novartis Investigative Site

Muenster, Germany - Not yet recruiting

Novartis Investigative Site

Offenbach, Germany - Not yet recruiting

Novartis Investigative Site

Rostock, Germany - Not yet recruiting

Novartis Investigative Site

Milano, MI - Not yet recruiting

Novartis Investigative Site

Rozzano, MI - Not yet recruiting

Novartis Investigative Site

Castellanza, VA - Not yet recruiting

Novartis Investigative Site

Udine, Italy - Not yet recruiting

Novartis Investigative Site

Hamilton, New Zealand - Not yet recruiting

Novartis Investigative Site

Bellavista, Lima - Not yet recruiting

Novartis Investigative Site

Jesus Maria, Lima - Not yet recruiting

Novartis Investigative Site

San Borja, Lima - Not yet recruiting

Novartis Investigative Site

Surquillo, Lima - Not yet recruiting

Novartis Investigative Site

Singapore, Singapore - Not yet recruiting

Novartis Investigative Site

Singapore, Singapore - Not yet recruiting

Novartis Investigative Site

Sevilla, Andalucia - Not yet recruiting

Novartis Investigative Site

Sevilla, Andalucia - Not yet recruiting

Novartis Investigative Site

Barcelona, Catalu¤a - Not yet recruiting

Novartis Investigative Site

Barcelona, Catalu¤a - Not yet recruiting

Novartis Investigative Site

Valencia, Comunidad Valenciana - Not yet recruiting

Novartis Investigative Site

Mallorca, Islas Baleares - Not yet recruiting

Novartis Investigative Site

Palma de Mallorca, Islas Baleares - Withdrawn

Novartis Investigative Site

Majadanonda, Madrid - Not yet recruiting

Novartis Investigative Site

Reus, Tarragona - Not yet recruiting

Novartis Investigative Site

Madrid, Spain - Not yet recruiting

Novartis Investigative Site

Madrid, Spain - Not yet recruiting

Novartis Investigative Site

Madrid, Spain - Not yet recruiting

Novartis Investigative Site

Madrid, Spain - Not yet recruiting

Novartis Investigative Site

Bern, Switzerland - Not yet recruiting

Novartis Investigative Site

Mendrisio, Switzerland - Not yet recruiting

For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.